Polaris Oligonucleotide

Polaris Oligonucleotides is a contract research organization specializing in advancing oligonucleotide science through high-quality, custom synthetic services. As oligonucleotide-based therapeutics grow increasingly complex, we focus on chemically modified oligonucleotides, oligoribonucleotides (RNA), and challenging syntheses across various scales. Leveraging our extensive synthetic experience, we provide custom syntheses of oligonucleotides and nucleoside monomers, enabling clients to access innovative solutions beyond standard commercial offerings. Our business model centers on supporting scientific advancements with tailored synthetic strategies for each project. Join our expanding client base by contacting us today to discuss your project or learn more about Polaris Oligonucleotides.